Your browser is unsupported
We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.
Bringing together Centre members from UI, pharma, bioventures, and others possessing knowledge and experience in chemical, pharmaceutical, and translational research with biomedical and clinical primary inventors at UI to provide and support project-based collaborations focused on discovery of novel chemical entities as viable clinical drug candidates.
Projects are created by exploiting critical mass at UI in areas of excellence, to create and support Incentive grants focused on treatment and eradication of specific diseases. Projects are selected by working closely with the Office of Technology Management (OTM) to exploit existing Invetion Disclossures (ID). In addition, two Campus wide RFAs are performed on a yearly basis in order to form multi-PI translational research grants and feed the pipeline for Project-Based Discovery.